Close Menu

NEW YORK (GenomeWeb) – Seegene today announced it has established Seegene Technologies, a new US subsidiary based in Concord, Calif.

The South Korean firm said it plans to enhance its sales in the US by directly managing existing clients and gaining new ones. Seegene will also pursue several US Food and Drug Administration submissions of reagents for multiplexed tests to detect respiratory and gastrointestinal infections.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.